Call for Papers and Posters
Computational
Studies of non-coding RNAs
A session at the Pacific Symposium on
Biocomputing 2010
January 4-8, 2010
The Big Island of Hawaii
Background and Motivation
Until recently, RNA has been viewed as a simple ``working copy'' of the
genomic DNA, simply transporting information from the genome into the
proteins. In the 1980s, this picture changed, to certain extent, with
the discovery of ribozymes and the realization that the ribosome is
essentially an ``RNA machine''. Since the turn of the millenium, however,
RNA has moved from a fringe topic to a central research topic following the
discovery of RNA interference (RNAi), the post transcriptional silencing of
gene expression via interactions between mRNAs and their regulatory RNAs.
More recent studies have revealed that a large fraction of the genome sequences
give rise to RNA transcripts that do not code for proteins. Those RNAs that do not
code for proteins are called non-coding RNAs (ncRNAs). A recent computational screen
estimated the number of small regulatory RNAs (srRNAs), which form an important
class of non-coding RNAs, in Arabidopsis thaliana to be in the order of 1.5 million.
Among srRNAs two subclasses form the bulk of all regulatory RNAs: microRNAs (miRNAs)
and small interfering RNAs (siRNAs) - which are of similar length (21 to 25 nt) and
composition but different by origin. It is predicted that these two subclasses
regulate at least one-third of all human genes. There are many other classes of
non-coding RNAs with functionalities beyond simple regulation of gene expression:
examples include snoRNAs, snRNAs, gRNAs, and stRNAs, which respectively perform
ribosomal RNA (rRNA) modification, RNA editing, mRNA splicing and developmental regulation.
The functionality of many such non-coding RNAs are only scarcely known.
In addition to such endogenous ncRNAs, antisense oligonucleotides have been used as
exogenous inhibitors of gene expression; antisense technology is now commonly used for
therapeutic purposes and as a research tool. The therapeutic objective of antisense
technology is to block the production of disease-causing proteins. In principle, these
artificial regulatory RNA molecules could be employed as drugs for the treatment of a
variety of human diseases such as several types of cancer, rheumatoid arthritis,
brain diseases, and viral infections. As a research tool, antisense nucleic acids may
be utilized as inputs to the metabolic network of a cell to control or interfere with
the dynamics and function of various modules in the network.
Furthermore, synthetic nucleic acid systems have been engineered to self assemble into
complex structures performing various dynamic mechanical motions. Despite advances in
computational studies of non-coding RNA, there are still many open areas and unresolved
issues particularly for high-throughput applications based on the new genome sequencing technologies.
Session Objective and Scope
The main objective of this session is to discuss new algorithms, software tools
and their applications in non-coding RNA bioinformatics.
Recent improvements in sequencing methods introduced high-throughput, low-cost, and cloning-free (thus less
labor-intensive) technologies. The
revolution in DNA sequencing will shortly result in an enormous collection of sequence data pertaining to
the genomes and transcriptomes of various human individuals from
different populations and also various species.
Exact and approximation, possibly high-throughput, algorithms and tools are therefore needed for non-coding RNA studies.
Specific topics include:
General
Information on Papers and Presentations
The scientific
core of the conference consists of rigorously peer-reviewed full-length papers
reporting on original work. Accepted papers will be published in an archival
proceedings volume (fully indexed in PubMed), and a number of the papers will
be selected for presentation during the conference. Researchers wishing to
present their research without official publication are encouraged to submit a
one-page abstract, and present their work in a poster session.
Paper
Formatting and Submission
Please see the PSB paper format template and instructions at http://psb.stanford.edu/psb-online/psb-submit.
The only acceptable file formats are Adobe Acrobat (*.pdf) and postscript
(*.ps). Attached files should be named with the last name of the first author
(e.g., altman.pdf or altman.ps). Hardcopy submissions or unprocessed TeX or
LaTeX files will be rejected without review.
Each paper must
be accompanied by a cover letter. The cover letter must state the following:
Submitted papers
are limited to twelve (12) pages
in the official PSB publication format. Please format your paper according to
these instructions, which can be found at
http://psb.stanford.edu/psb-online/psb-submit/. If figures cannot be easily
resized and placed precisely in the text, then it should be clear that with
appropriate modifications, the total manuscript length would be within the page
limit.
Important
Dates
Session Co-Chairs
Rolf Backofen
Institute of Computer Science, Albert-Ludwigs-University Freiburg, Germany
backofen@informatik.uni-freiburg.de
Hamidreza Chitsaz
School of Computing Science, Simon Fraser University,
Canada
hrc4@cs.sfu.ca
Ivo Hofacker
Institute for Theoretical Chemistry, University of Vienna, Austria
ivo@tbi.univie.ac.at
S. Cenk Sahinalp
School of Computing Science, Simon Fraser University, Canada
cenk@cs.sfu.ca
Peter F. Stadler
University of Leipzig, Germany
studla@bioinf.uni-leipzig.de